These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 16417216

  • 21. Cardioprotection from oxidative stress in the newborn heart by activation of PPARγ is mediated by catalase.
    Chen T, Jin X, Crawford BH, Cheng H, Saafir TB, Wagner MB, Yuan Z, Ding G.
    Free Radic Biol Med; 2012 Jul 15; 53(2):208-15. PubMed ID: 22609424
    [Abstract] [Full Text] [Related]

  • 22. Selective effects of PPARgamma agonists and antagonists on human pre-adipocyte differentiation.
    Leyvraz C, Suter M, Verdumo C, Calmes JM, Paroz A, Darimont C, Gaillard RC, Pralong FP, Giusti V.
    Diabetes Obes Metab; 2010 Mar 15; 12(3):195-203. PubMed ID: 19895635
    [Abstract] [Full Text] [Related]

  • 23. 15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells.
    Hovsepian E, Penas F, Goren NB.
    Shock; 2010 Jul 15; 34(1):60-7. PubMed ID: 19997048
    [Abstract] [Full Text] [Related]

  • 24. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
    Yamamoto A, Kakuta H, Sugimoto Y.
    Int Immunopharmacol; 2014 Sep 15; 22(1):204-8. PubMed ID: 24975659
    [Abstract] [Full Text] [Related]

  • 25. Chimyl Alcohol Suppresses PGE2 Synthesis by Human Epidermal Keratinocytes through the Activation of PPAR-γ.
    Yokota M, Yahagi S, Tokudome Y, Masaki H.
    J Oleo Sci; 2018 Apr 01; 67(4):455-462. PubMed ID: 29526871
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes.
    Mendez M, LaPointe MC.
    Hypertension; 2003 Oct 01; 42(4):844-50. PubMed ID: 12885795
    [Abstract] [Full Text] [Related]

  • 28. The Pro-Differentiation Effect of Doxycycline on Human SZ95 Sebocytes.
    Zouboulis CC, Ní Raghallaigh S, Schmitz G, Powell FC.
    Dermatology; 2021 Oct 01; 237(5):792-796. PubMed ID: 33091909
    [Abstract] [Full Text] [Related]

  • 29. Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
    Hazra S, Dubinett SM.
    Prostaglandins Leukot Essent Fatty Acids; 2007 Jul 01; 77(1):51-8. PubMed ID: 17697767
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug 01; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 32. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Xin B, Yokoyama Y, Shigeto T, Futagami M, Mizunuma H.
    Cancer; 2007 Aug 15; 110(4):791-800. PubMed ID: 17582802
    [Abstract] [Full Text] [Related]

  • 33. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M, Martín AR, Villegas I, de la Lastra CA.
    Eur J Pharmacol; 2007 May 21; 562(3):247-58. PubMed ID: 17343846
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
    Jayaraj P, Sen S, Bhattacharya T, Arora J, Yadav S, Chhoker V, Kumar A, Dhanaraj PS, Yadavilli KS, Verma M.
    Histopathology; 2016 Aug 21; 69(2):268-75. PubMed ID: 26791964
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R, Kurosaki E, Yoshida S, Yokono M, Shimaya A, Maruyama T, Shibasaki M.
    Biochem Pharmacol; 2006 Jun 28; 72(1):42-52. PubMed ID: 16696951
    [Abstract] [Full Text] [Related]

  • 38. PGD2 induces eotaxin-3 via PPARγ from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis.
    Nakahigashi K, Doi H, Otsuka A, Hirabayashi T, Murakami M, Urade Y, Zouboulis CC, Tanizaki H, Egawa G, Miyachi Y, Kabashima K.
    J Allergy Clin Immunol; 2012 Feb 28; 129(2):536-43. PubMed ID: 22206772
    [Abstract] [Full Text] [Related]

  • 39. Estrogen improves vascular function via peroxisome-proliferator-activated-receptor-γ.
    Tiyerili V, Müller CF, Fung S, Panek D, Nickenig G, Becher UM.
    J Mol Cell Cardiol; 2012 Aug 28; 53(2):268-76. PubMed ID: 22634137
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.